ASLAN PharmaASLN

ASLAN Pharmaceuticals Ltd is a clinical-stage immunology-focused biopharmaceutical company developing innovative treatments to transform the lives of patients.

4.2 / 55 reviews
46% recommend to a friend

$68.7M

Market Cap • 02/06/2023

2014

(9 years ago)
Founded

2018

(5 years ago)
IPO

Singapore

34

Employees 2022

Valuation

Valuation Indicators
YearEquityRevenueEBITDAFin. Res.Net Inc.Net Mar.ROECashDebtN.D. / EBITDAOCFCAPEXFCFFreeDiv.
03/23 TTM100-54-3-58LL5738L-3805-380

The values above are represented in USD and the scale is in millions—10.000 is the equivalent of 10 billions. L inside the table means Loss.